Clinical Trials on Polypoid Choroidal Vasculopathy (PCV) in Korea, Democratic People's Republic of
Total 13 results
-
Novartis PharmaceuticalsRecruitingMacular Polypoidal Choroidal Vasculopathy (PCV)Korea, Republic of
-
Seoul St. Mary's HospitalUnknownPolypoidal Choroidal VasculopathyKorea, Republic of
-
Asan Medical CenterUnknownPolypoidal Choroidal VasculopathyKorea, Republic of
-
Yeungnam University College of MedicineUnknownPolypoidal Choroidal VasculopathyKorea, Republic of
-
Kim's Eye HospitalCompletedAge-Related Macular Degeneration | Choroidal Neovascularization | Polypoidal Choroidal VasculopathyKorea, Republic of
-
Samsung Medical CenterUnknownPolypoidal Choroidal Vasculopathy | Central Serous ChorioretinopathyKorea, Republic of
-
Mateon TherapeuticsCompletedPolypoidal Choroidal VasculopathyUnited States, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
Samsung Medical CenterBayer; Seoul National University Bundang Hospital; Kim's Eye HospitalCompletedPolypoidal Choroidal Vasculopathy Without Active PolypKorea, Republic of
-
NovartisCompletedPolypoidal Choroidal VasculopathyHong Kong, Taiwan, Singapore, Korea, Republic of, Thailand
-
Pusan National University HospitalNovartisUnknownPolypoidal Choroidal Vasculopathy | Exudative Age-related Macular DegenerationKorea, Republic of
-
Pusan National University HospitalBayerCompletedPolypoidal Choroidal Vasculopathy | Exudative Age-related Macular DegenerationKorea, Republic of
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Polypoidal Choroidal VasculopathyJapan, Taiwan, Hong Kong, Singapore, Thailand, Korea, Republic of, Malaysia
-
AllerganCompletedChoroidal Neovascularization | Age-Related MaculopathyFrance, Korea, Republic of, New Zealand, Italy, Israel, United States, Portugal, Australia, United Kingdom